HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump's Chinese Import Tariff Hike Could Take Toll On Consumer Health Sector

This article was originally published in The Pink Sheet & The Rose Sheet

Executive Summary

Low margins, limited supplier alternatives leave little room for OTC drug marketers in the US to maneuver as ingredients continue  to be subject to Chinese import tariffs.

 

You may also be interested in...



Full Plate Of Dietary Ingredients In Latest US Tariff Hikes On Chinese Imports

Consumer health industry groups plan to comment at June 17 public hearing on USTR plan for 25% tariff on imports from China not included in three earlier rounds of duties. NPA applauds USTR for allowing exclusion process for imported products valued at $200bn already hit with tariffs in 2018.

Supplement Firms Work On Mitigating Import Tariff Costs Before Raising Prices

Supplement marketers, Chinese suppliers and US retailers likely will work out mitigating costs from US-China trade war, which ratcheted up this month with Trump administration’s proposed fourth round of tariffs. Some companies are discussing cost mitigation with retailers, but others seek other suppliers.

J&J CEO Sees Victory Ahead On Talc, Growth From Johnson's Relaunch

JP Morgan analysts had questions and J&J CEO Alex Gorsky and CFO Joseph Wolk had answers about liability suits alleging that use of the Johnson's brand talcum powder has caused mesothelioma or ovarian cancer. On the Johnson's brand outlook following its relaunch as a natural product line, Gorsky says sales were a key driver in the firm's consumer health sales in the 2018 third quarter. China, meanwhile, is a model for growing sales online, he says.

Related Content

Topics

UsernamePublicRestriction

Register

RS122645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel